Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: A secondary analysis of the TAILORx randomized clinical trial
- Publication date
- 1 March 2020
- Publisher
- Advocate Aurora Health Institutional Repository